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GISA (Glycopeptide-lntermediate Staphylococcus 
aureus) Selected by Vancomycin Treatment 
of Experimental Endocarditis Persist after 
Treatment Arrest In Vivo, but are not Detected 
by Vegetation Cultures In Vitro 
J.M. Entenza*, J. Vouillamoz, M. Giddey, 
P. Moreillon. Department o[ Fundamental 
Microbiology BB - University o[ Lausanne, 
CH- 1015 Lausanne, Switzerland 
Background: Laboratory diagnosis of glycopeptide- 
intermediate Staphylococcus aureus (GISA) and 
their heterogeneous-GISA (h-GISA) precursors is 
difficult. Thus, it is possible that vancomycin fail- 
ures against supposedly vancomycin-susceptible 
S. aureus are in fact due to GISA or h-GISA. 
We tested this hypothesis during vancomycin 
treatment of experimental endocarditis due 
to a vancomycin-susceptible, methicillin-resistant 
S. aureus (MRSA). 
Methods: Rats with aortic experimental endocardi- 
tis due to the vancomycin-susceptible MRSA M1 
were treated with human-like kinetics of van- 
comycin (1 g i.v. every 12 h). Treatment was started 
16 h after bacteria[ challenge and given for 2 days. 
Groups were killed either at the start of ther- 
apy, 8h or 3 days after treatment arrest. Pop- 
ulation analysis was done directly on vegetation 
homogenates, or after 1 subculture in drug-free 
medium to mimic standard diagnostic procedures. 
Results: The vancomycin-susceptible parent had an 
MIC of vancomycin of 2 mg/l, and grew on <4 mg/l 
in population analysis. Eight hours after treatment 
arrest, 6/13 rats had still positive valve cultures, 
one of which was harboring an h-GISA (growing 
on 8 mg/l of vancomycin in population analysis). 
Three days after treatment arrest, 6/13 rats had 
positive valve cultures, all of which was harboring 
h-GISA (growing on 8 mg/l of vancomycin). In con- 
trast, 1 single subculture of vegetations in drug- 
free broth was enough to revert all the h-GISA to 
the susceptible pattern of the parent. 
Conclusions: Vancomycin selected for h-GISA dur- 
ing therapy of experimental endocarditis due to 
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vancomycin-susceptible S. aureus. These h-GISA 
were associated with vancomycin failure. The 
h-GISA phenotype persisted in vivo even after ar- 
rest of vancomycin. On the other hand, the h-GISA 
phenotype was missed in vitro after a single pas- 
sage on drug-free medium. Thus, h-GISA escape de- 
tection in clinical samples if they are subcultured 
before susceptibility tests. 
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Age Limits do not Replace Serologic Tests for 
Immune Status Against Measles 
I. U~:kay*, S. Hugonnet, N. Bessire, L. Kaiser, 
C.A. Siegrist, D. Pittet. Division o[ In[ectious 
Diseases Geneva University Hospitals, Geneva, 
Switzerland 
Background: Measles are a highly contagious and 
preventable childhood infection. Disease may be 
severe in adults and a single dose of vaccine pro- 
tects only to 90%. Because of a herd immunity 
(max. 85% vaccine coverage, seroprevalence <95%) 
epidemics regularly occur in Switzerland and in 
other countries. According to common belief and 
federal recommendations, persons over 40 years 
of age are considered immune due to childhood 
exposure before vaccine availabNty since 1964. We 
questioned this presumption by a mass serologic 
screening in the University HosNta[s of Geneva. 
Methods: In January 2005 4 Health Care Workers 
(HCW) were victim of a nosocomial outbreak and 
35 other persons (8 adults and 27 adolescents) 
developed measles in the community. By fear of 
a large epidemic and lack of knowledge of the 
immunity status of HCWs, a mass screening and/or 
vaccination campaign was started. The serologic 
exams were made by XXX. 
Results: 117 of 2600 adult HCWs and patients 
were seronegative for measles (4.5%). 31 seroneg- 
ative persons were older than 40 years (26% of all 
seronegative adults), the oldest being a 76 years 
old HCW. 13 HCWs were immunocompetent and 
1 HCW had smoldering myeloma. Among 7 patients 
had transplantation (TPL): 2 bone marrow TPL, 
4 renal TPL and 1 cardiac TPL, 1 had cirrhosis and 
